Official SEC submissions

Atrium Therapeutics SEC Filings

Direct answer

Atrium Therapeutics's latest SEC filing is 8-K.

It was filed on November 2, 2026, and 30 recent filings are available.
Each row links directly to the SEC document and filing index.

Get free Atrium Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

8-K

Current report

Filed:

Report date:

8-K

8-K

Current report

Filed:

Report date:

8-K

8-K/A

Current report

Filed:

Report date:

8-K/A

8-K

Current report

Filed:

Report date:

8-K

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

10-Q

Periodic report

Filed:

Report date:

10-Q

8-K

Current report

Filed:

Report date:

8-K

8-K

Current report

Filed:

Report date:

8-K

10-Q

Periodic report

Filed:

Report date:

10-Q

8-K

Current report

Filed:

Report date:

8-K

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

4

Insider transaction

Filed:

Report date:

4

8-K

Current report

Filed:

Report date:

8-K

8-K

Current report

Filed:

Report date:

8-K

Verified data

Recent filing categories
3
Recent filings
30
SEC CIK
0002093101
Latest filing date
November 2, 2026